CB terms amended: higher yield, extended maturity
바이오솔루션
086820
Signal Score
Historical Avg Return (5d)
+0.00%
Data Coverage
100%n=2692
Risk-adjusted indicator based on 2692 historical DART filings. For informational purposes only — not investment advice.
Financial Impact
NEGATIVE
Key Numbers
- • Maturity Interest Rate: 4.0% (previously 1.0%)
- • Put Option Yield: 4.00% (previously 1.00%)
- • Bond Maturity Date: August 13, 2027 (extended from August 13, 2026)
- • Remaining CB Principal: 18.0B KRW (held by bondholders)
- • Maximum Dilution Rate: 9.93% (based on 2,576,581 convertible shares)
AI Analysis Summary
Bio Solution Co.,Ltd. has amended the terms of its convertible bonds (CBs), increasing the maturity interest rate and put option yield from 1.0% to 4.0% and extending the maturity date by one year to August 13, 2027. This amendment, driven by agreement with bondholders, makes the CBs more attractive to holders but increases the company's financial burden. The remaining CB principal held by bondholders is 18.0B KRW, with a potential maximum dilution rate of 9.93% from 2,576,581 convertible shares. The original funds were used for business expansion, acquisition of Helixmith shares, and M&A activities. The increased cost of financing and extended maturity could negatively impact profitability and shareholder value.
How This Event Is Evaluated
Capital Raise Evaluation
Capital raise events are evaluated by estimating dilution pressure, funding purpose, pricing terms, and impact on existing shareholders.
AI is used to interpret disclosures and extract structured data.
Signal scores are generated using event-specific methodologies and quantitative models.
- Potential dilution rate
- Issuance or conversion price
- Funding purpose
- Shareholder value impact
This content is for informational purposes only and does not constitute investment advice. Past signal patterns do not guarantee future results. All data is sourced from public DART filings.